Your session is about to expire
← Back to Search
Behavioral Intervention
Psychotherapy for Suicidal Thoughts in Young People
N/A
Recruiting
Led By Robert J Gregory, MD
Research Sponsored by State University of New York - Upstate Medical University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 months
Awards & highlights
Study Summary
This trial assesses whether DDP is more effective than BIC in reducing suicidality among suicidal teens/young adults. Participants receive treatment with safety planning & optional medication mgmt at SUNY Upstate's PHRP for up to 1 year.
Who is the study for?
This trial is for adolescents and young adults aged 14-40 with suicidal thoughts who are fluent in English. They must be willing to be video-recorded, attend outpatient treatment, and have certain scores on suicide ideation scales. It excludes those with schizophrenia, schizoaffective disorder, autism spectrum disorder, low BMI or IQ, or current treatment with DDP or specific medications.Check my eligibility
What is being tested?
The study compares Dynamic Deconstructive Psychotherapy (DDP) against Brief Intervention and Contact (BIC), both supplemented by safety planning and optional medication management. Participants will randomly receive either DDP or BIC at SUNY Upstate Medical University's Psychiatry High Risk Program for up to one year.See study design
What are the potential side effects?
Since this trial involves psychotherapy interventions rather than drugs, typical medical side effects are not expected. However, participants may experience emotional discomfort during therapy sessions as they explore difficult personal issues related to their suicidality.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from Baseline in Suicide Ideation on the Combined Suicide Ideation (CSI) Score at 6 Months of Treatment
Secondary outcome measures
Change from Baseline in Anxiety on the Generalized Anxiety Disorder 7-Item Scale (GAD-7) at 6 Months of Treatment
Change from Baseline in Depression on the Patient Health Questionnaire-9 (PHQ-9) Scale at 6 Months of Treatment
Change from Baseline in Identifying Emotions on the Toronto Alexithymia Scale (TAS20) at 6 Months of Treatment
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Dynamic Deconstructive Psychotherapy (DDP)Experimental Treatment1 Intervention
53 participants will meet with an assigned DDP therapist in-person or through televideo for 50 to 60 minutes on a weekly basis for 12 months. Participants will also meet with a psychiatric provider for a 60-minute psychiatric consultation with at least monthly 30-minute follow-up visits. In addition, participants in this arm will have the option of attending family and group therapy if interested and indicated. At baseline, 3, 6, 9, and 12 months, participants will meet with a research coordinator for 60-minute visits to complete outcome measures.
Group II: Brief Intervention and Contact (BIC)Active Control1 Intervention
53 participants will meet with an assigned BIC therapist in-person or through televideo for an initial 60-minute visit with eight 30-minute follow-up contacts at 1, 2, 4 weeks and 2, 3, 4, 6 and 12 months after study entry. Participants will also meet with a psychiatric provider for a 60-minute psychiatric consultation with at least monthly 30 minute follow-up visits. In addition, participants in this arm will be encouraged to receive services in the community, such as weekly individual psychotherapy, family and group therapy. At baseline, 3, 6, 9, and 12 months, participants will meet with a research coordinator for 60-minute visits to complete outcome measures.
Find a Location
Who is running the clinical trial?
State University of New York - Upstate Medical UniversityLead Sponsor
173 Previous Clinical Trials
27,351 Total Patients Enrolled
Robert J Gregory, MDPrincipal InvestigatorState University of New York - Upstate Medical University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 14 and 40 years old.I am willing to start outpatient treatment and have seen a psychiatrist.My BMI is below 18 if I'm an adult, or below 17 if I'm a teenager.I have undergone or am undergoing Dynamic Deconstructive Psychotherapy.I am willing to be video-recorded.I am currently receiving ECT, ketamine, or esketamine treatments.
Research Study Groups:
This trial has the following groups:- Group 1: Dynamic Deconstructive Psychotherapy (DDP)
- Group 2: Brief Intervention and Contact (BIC)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger